Device, Implant and Skin Substitute Payment Policy #3983
Policy Update #: POLPAY01222027
Effective Date: 1/22/2027
Current State: Medicaid, Medicare, and Commercial policy guidance was combined under Policy #3983.
Future State:
- Medicare: Payment Policy #3983- Device, Implant, and Skin Substitute Payment Policy will retire the Medicare line of business from the policy effective December 31, 2026. Providers should refer to the Centers for Medicare & Medicaid Services (CMS) for all guidance related to devices, implants, and skin substitutes following retirement of this policy.
- Medicaid & Commercial Plans: Payment Policy #3983 Device, Implant, and Skin Substitute Payment Policy has undergone its annual review and update. The policy has been restructured into two separate policies for greater clarity and alignment by line of business. Providers should carefully review the updated policies to understand the changes and ensure appropriate billing and documentation practices.
- Summary of Changes: Retirement of the Medicare line of business; Separation of Medicaid and Commercial policies; Clarification added for billing, coding, documentation and reimbursement requirements, including but not limited to, clarification of same-claim and same-date-of-service reporting requirements; expanded guidance for device credits, replacement devices, skin substitutes, and revenue code 0278.
Applicable Plan(s): Medicare, Medicaid and Commercial
Applicable Policy: #3983
Business Owner: Cost of Care
Download and Print:
Provider News
Provider Updates
Payment Policy Updates, Revised Sentara Health Plans Medicaid provider manual now available
Policy Update
Device, Implant and Skin Substitute Payment Policy #3983
Provider News
Provider News Q4 Fall 2026
Provider Updates
Update information to reflect Sentara Health Plans, new preferred durable medical equipment provider, and more